Private equity group Carlyle is caught up in a dispute over Neochimiki, the Athens-based chemicals distributor it acquired last year, according to the Financial Times.
In order to view premium content you need to be a Premium Subscriber. You can subscribe now to access premium online content.
Become a Premium SubscriberIf you are already a AltAssets subscriber please log in below.